drugset / Trial / NCT07836270

A Study of Ecnoglutide Injection in Overweight or Obese Chinese Adolescents

NCT07836270 ↗

Phase 3 Not yet recruiting 192 enrolled Hangzhou Sciwind Biosciences Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of the study is to evaluate the safety and efficacy of Ecnoglutide injection in overweight or obese Chinese adolescents

Timeline

Start
2026-10-31
Primary completion
2028-06-08
Completion
2028-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Ecnoglutide Protein / enzyme biologic — Subcutaneous

Indications

No indication recorded.